Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-ablative 1,550 nm Fractional Laser Therapy Versus Triple Topical Therapy for the Treatment of Melasma: a Randomized Controlled Split-face Study

NCT01085279 is registered in ClinicalTrials.gov with Netherlands Institute for Pigment Disorders as lead sponsor.

NCT NCT01085279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01085279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-ablative 1,550 nm Fractional Laser Therapy Versus Triple Topical Therapy for the Treatment of Melasma: a Randomized Controlled Split-face Study
Lead sponsor
Netherlands Institute for Pigment Disorders
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
February 28, 2010
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pigmentation disorder